61 related articles for article (PubMed ID: 18299666)
1. Managing chronic hepatitis C in relapsers and non-responders.
Montalbano M; Kemmer N; Neff GW
Minerva Gastroenterol Dietol; 2008 Mar; 54(1):31-47. PubMed ID: 18299666
[TBL] [Abstract][Full Text] [Related]
2. Managing chronic hepatitis C in the difficult-to-treat patient.
Kemmer N; Neff GW
Liver Int; 2007 Dec; 27(10):1297-310. PubMed ID: 18036096
[TBL] [Abstract][Full Text] [Related]
3. [HCV non-responder patients: definition of non-response and treatment strategy].
Marcellin P; Bourlière M; Pawlotsky JM; Ouzan D
Gastroenterol Clin Biol; 2007; 31(8-9 Pt 3):4S13-9. PubMed ID: 17965630
[TBL] [Abstract][Full Text] [Related]
4. Optimizing treatment outcomes in chronic hepatitis C: management of non-response.
Pol S; Bourlière M
Antivir Ther; 2006; 11(8):955-70. PubMed ID: 17302365
[TBL] [Abstract][Full Text] [Related]
5. Chronic hepatitis C: retreatment of relapsers. An evidence-based approach.
Cammà C; Craxì A
Semin Gastrointest Dis; 2000 Apr; 11(2):115-21. PubMed ID: 10803635
[TBL] [Abstract][Full Text] [Related]
6. Management of nonresponsive hepatitis C.
Bailly F; Ahmed SN; Pradat P; Trepo C
Expert Rev Anti Infect Ther; 2010 Apr; 8(4):379-95. PubMed ID: 20377334
[TBL] [Abstract][Full Text] [Related]
7. The kidney transplant recipient with hepatitis C infection: pre- and posttransplantation treatment.
Terrault NA; Adey DB
Clin J Am Soc Nephrol; 2007 May; 2(3):563-75. PubMed ID: 17699464
[TBL] [Abstract][Full Text] [Related]
8. Retreatment of chronic hepatitis C virus infection in patients who failed to achieve sustained virologic response.
Shiffman ML
Minerva Gastroenterol Dietol; 2004 Mar; 50(1):37-49. PubMed ID: 15719005
[TBL] [Abstract][Full Text] [Related]
9. Virological relapse in chronic hepatitis C.
Poordad FF; Flamm SL
Antivir Ther; 2009; 14(3):303-13. PubMed ID: 19474464
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C virus therapy in liver transplant recipients: response predictors, effect on fibrosis progression, and importance of the initial stage of fibrosis.
Roche B; Sebagh M; Canfora ML; Antonini T; Roque-Afonso AM; Delvart V; Saliba F; Duclos-Vallee JC; Castaing D; Samuel D
Liver Transpl; 2008 Dec; 14(12):1766-77. PubMed ID: 19025933
[TBL] [Abstract][Full Text] [Related]
11. Treatment of chronic hepatitis C virus infection - Dutch national guidelines.
de Bruijne J; Buster EH; Gelderblom HC; Brouwer JT; de Knegt RJ; van Erpecum KJ; Schalm SW; Bakker CM; Zaaijer HL; Janssen HL; Reesink HW;
Neth J Med; 2008; 66(7):311-22. PubMed ID: 18663263
[TBL] [Abstract][Full Text] [Related]
12. [Alternative treatments for patients with chronic C hepatitis who did not respond previous treatments].
Diago M
Rev Gastroenterol Mex; 2005; 70(4):458-64. PubMed ID: 17058986
[TBL] [Abstract][Full Text] [Related]
13. Impact and management of hepatitis B and hepatitis C virus co-infection in HIV patients.
Kumar R; Singla V; Kacharya Sk
Trop Gastroenterol; 2008; 29(3):136-47. PubMed ID: 19115605
[TBL] [Abstract][Full Text] [Related]
14. Factors associated with adherence to combination therapy of interferon and ribavirin for patients with chronic hepatitis C: importance of patient's motivation and physician's treatment experience.
Tanioka D; Iwasaki Y; Araki Y; Osawa T; Ikeda H; Ando M; Kobashi H; Sakaguchi K; Shiratori Y; Yamamoto K
Liver Int; 2009 May; 29(5):721-9. PubMed ID: 19141025
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of low-dose intermittent interferon-alpha monotherapy in patients infected with hepatitis C virus genotype 1b who were predicted or failed to respond to pegylated interferon plus ribavirin combination therapy.
Akuta N; Suzuki F; Kawamura Y; Yatsuji H; Sezaki H; Suzuki Y; Hosaka T; Kobayashi M; Kobayashi M; Arase Y; Ikeda K; Kumada H
J Med Virol; 2008 Aug; 80(8):1363-9. PubMed ID: 18551610
[TBL] [Abstract][Full Text] [Related]
16. Early and accurate prediction of Peg-IFNs/ribavirin therapy outcome in the individual patient with chronic hepatitis C by modeling the dynamics of the infected cells.
Colombatto P; Ciccorossi P; Maina AM; Civitano L; Oliveri F; Coco B; Romagnoli V; Bonino F; Brunetto MR
Clin Pharmacol Ther; 2008 Aug; 84(2):212-5. PubMed ID: 18388885
[TBL] [Abstract][Full Text] [Related]
17. [Current opportunities for treatment of chronic hepatitis C in patients with HIV co-infection].
Inglot M; Szymczak A; Gasiorowski J
Przegl Epidemiol; 2008; 62(2):383-91. PubMed ID: 18807485
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C therapy before and after liver transplantation.
Terrault NA
Liver Transpl; 2008 Oct; 14 Suppl 2():S58-66. PubMed ID: 18825697
[TBL] [Abstract][Full Text] [Related]
19. Viral hepatitis C.
Leevy CB; Zierer KG; Leevy CM
J Assoc Acad Minor Phys; 1998; 9(4):59-64. PubMed ID: 10825999
[TBL] [Abstract][Full Text] [Related]
20. [Chronic hepatitis C: management of side effects of treatment].
Larrey D; Couzigou P; Denis J
Gastroenterol Clin Biol; 2007; 31(8-9 Pt 3):4S20-8. PubMed ID: 17965631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
